Cornetta, KennethKay, SamanthaUrio, FlorenceMinja, Irene KidaMbugi, ErastoMgaya, JosephineMselle, TeddyNkya, SianaAlimohamed, Mohamed ZahirNdaki, KinumaBonamino, MartínKoya, Richard C.Shah, Lesha D.Mahlangu, JohnnyDrago, DanielaRangarajan, SavitaJayandharan, Giridhara Rao2024-10-282024-10-282023Cornetta K, Kay S, Urio F, et al. Implementation of a gene therapy education initiative by the ASGCT and Muhimbili University of Health and Allied Sciences. Mol Ther. 2023;31(9):2561-2565. doi:10.1016/j.ymthe.2023.07.019https://hdl.handle.net/1805/44279There has been rapid growth in gene therapy development with an expanding list of approved clinical products. Several therapies are particularly relevant to patients in low- and middle-income countries. Moreover, investing in research and manufacturing presents an opportunity for economic development. To increase awareness of gene therapy, the American Society of Gene and Cell Therapy partnered with the Muhimbili University of Health and Allied Sciences, Tanzania, to create a certificate-bearing course. The goal was to provide faculty teaching in graduate and medical schools with the tools needed to add gene therapy to the university curriculum. The first virtual course was held in October of 2022, and 45 individuals from 9 countries in Africa completed the training. The content was new to approximately two-thirds of participants, with the remaining third indicating that the course increased their knowledge base. The program was well received and will be adapted for other under-resourced regions.en-USPublisher PolicyCell- and tissue-based therapyGenetic therapyHumansArticle